New SEC Form D filing
Pluri Inc., 2026-09-04
A new SEC Form D private-offering notice from Haifa, a $3,677,751 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Biotechnology company developing cell based products and therapeutics for regenerative medicine, immunotherapy, food tech, and agtech
Filed 5 days agoFiled to raise $3,677,751First money in 2026-08-28Raised so far $3,677,751HQ (as filed) HaifaSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified pluri-biotech.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Gossamer Bio, Inc., 2026-09-04, $150M, San Diego, CA
- JUPITER NEUROSCIENCES, INC., 2026-09-04, $775K, Palm Beach Gardens, FL
- Immunophotonics, Inc., 2026-09-04, St. Louis, MO
- Superluminal Medicines, Inc., 2026-09-03, $65.5M, Boston, MA
- Inventure, LLC, 2026-09-03, $82K, Southbury, CT
- Dravite Therapeutics, Inc., 2026-09-03, $53M, San Francisco, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.